Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Annou

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750's Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750's Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston , Massachusetts , United States , China , Rio De Janeiro , Estado Do Rio , Brazil , London , City Of , United Kingdom , Oberland , Thün , Germany , Chinese , Orexin Ataxin , Indiens Wirtschaft , Ihre Chancen , Kristenk Sheppard , Mario Alberto Accardi , Centessa Orexin Agonist Program , World Sleep Congress , Exchange Commission , Centessa Pharmaceuticals , Nasdaq , Narcolepsy Type , Sarah Wurts Black Phd , Orexin Agonist Program , Oral Selective Orexin Receptor , Promotes Wakefulness , Reduces Cataplexy , Mario Alberto Accardi Phd , Orexin Agonist , Saurabh Saha , Chief Executive Officer , World Sleep , Annual Report , Quarterly Reports , Investor Relations , Der Indien , Die Highlights ,